31hP

31hP
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay42706-5 5 mg -

6 - 10 business days*

136.00€
Cay42706-10 10 mg -

6 - 10 business days*

244.00€
Cay42706-25 25 mg -

6 - 10 business days*

577.00€
Cay42706-50 50 mg -

6 - 10 business days*

1,018.00€
 
31hP is an ionizable cationic lipid (pKa = 6.25) that has been used in the generation of lipid... more
Product information "31hP"
31hP is an ionizable cationic lipid (pKa = 6.25) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA and single-guide RNA (sgRNA) in vitro and in vivo. Intravenous administration of LNPs containing 31hP and encapsulating mRNA encoding Cas9 and sgRNA targeting transthyretin (TTR) reduce serum TTR levels in mice to a greater extent than those containing DLin-MC3-DMA (Cay-34364). Intramuscular administration of LNPs containing 31hP and encapsulating mRNA encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein increases serum antibody titers in mice to a greater extent than those containing SM-102 (Cay-33474).. Solulibility: Ethanol: Soluble: =10 mg/ml: .
Keywords: undecan-3-yl 4-(1-((2-(diethylamino)ethyl)(methyl)amino)-7-(heptadecan-9-yloxy)-7-oxohept-2-yn-1-yl)benzoate
Supplier: Cayman Chemical
Supplier-Nr: 42706

Properties

Application: Ionizable cationic lipid, LNP formation
MW: 767.24 D
Formula: C49H86N2O4
Purity: >95%
Format: Solution

Database Information

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H225, H319, H333
P Phrases: P210, P233, P240, P241, P242, P243, P264, P280, P303+361+353, P304+312, P305+351+338, P337+313, P370+378, P403+235, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "31hP"
Write a review
or to review a product.
Viewed